Sudden Cardiac Death in Dialysis: Do Current Guidelines for Implantable Cardioverter Defibrillator Therapy Apply to Patients with End-stage Kidney Disease

Seminars in Dialysis, 04/26/2012

Observational data suggest that secondary preventative implantable cardioverter defibrillator therapy following resuscitated cardiac arrest prolongs the lives of dialysis patients. This intervention may also offer a survival advantage as a primary preventative strategy in end–stage kidney disease. However, competing risk from co–morbidity can negate any perceived benefit.

Print Article Summary Cat 2 CME Report